z-logo
open-access-imgOpen Access
Imported Lassa Fever in Germany: Surveillance and Management of Contact Persons
Author(s) -
Walter Haas,
Thomas Breuer,
G Pfaff,
Herbert Schmitz,
Paivi Kohler,
Marcel Asper,
Petra Emmerich,
Christian Drosten,
Uta Gölnitz,
Klaus Fleischer,
Stephan Günther
Publication year - 2003
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/374853
Subject(s) - lassa fever , medicine , lassa virus , ribavirin , transmission (telecommunications) , viral hemorrhagic fever , arenavirus , virology , virus , immunology , ebola virus , hepatitis c virus , electrical engineering , engineering , cd8 , lymphocytic choriomeningitis , antigen
This study sought to assess the risk of secondary transmission after import of Lassa fever into Europe. A total of 232 persons exposed to a case of Lassa fever imported into Germany were identified. The level of exposure was determined for 157 persons (68%), and 149 (64%) were tested serologically. High-risk or close contact was reported by 30 (19%) of 157 persons. No symptomatic secondary infections were observed. However, Lassa virus-specific immunoglobulin G antibodies were detected in a serum sample obtained from a physician who examined the index patient on day 9 of illness. The physician received ribavirin prophylaxis and did not develop symptoms of Lassa fever. On the basis of these data, the contact was classified as having a probable secondary infection. The study indicates a low risk of transmission during the initial phase of symptomatic Lassa fever, even with high-risk exposures. The risk may increase with progression of disease and increasing virus load.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom